Interní Med. 2013; 15(8-9): 261-262

Interestitial lung diseases - why the diagnosis matters?

MUDr.Martina Šterclová, Ph.D., doc.MUDr.Martina Vašáková, Ph.D.
Pneumologická klinika 1. lékařské fakulty Univerzity Karlovy a Thomayerovy nemocnice, Praha

Interstitial lung fibrosis is a term used to generally descibe wide group of disorders with different etiology, treatment possibilities and

prognosis. In the cases, where any of either patients internal diseases or medication may lead to lung involvement, new manifestation

or worsening of preexisting dyspnoea should lead to lung investigation. Because diagnosis establishment and treatment is quite specific

in patients with interstitial lung disorders, they should be concentrated into specialized centers. Past treatment modalities were

based mainly on systemic corticosteroids. Recently new treatment possibilities including biologics have emerged and could dramaticaly

change the grim prognosis of before all of patients with idiopathic pulmonary fibrosis.

Keywords: interstitial lung diseases, diagnosis, treatment, prognosis

Published: October 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šterclová M, Vašáková M. Interestitial lung diseases - why the diagnosis matters? Interní Med. 2013;15(8-9):261-262.
Download citation

References

  1. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304. Go to original source... Go to PubMed...
  2. Vašáková M. a kol. Intersticiální plicní procesy. Praha: Maxdorf 2011: 410.
  3. Attili AK, Kazerooni EA, Gross BF, Flaherty KR, Myers JL, Martinez FJ. Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. RadioGraphics 2008; 28: 1383-1396. Go to original source... Go to PubMed...
  4. Vašáková M, Šterclová M. Idiopatická plicní fibróza- doporučený postup pro diagnózu, léčbu a sledování (1. aktualizace). Dostupný na WWW: <http://www.pneumologie.cz/odborne/doc/Idiopaticka%20plicni%20fibroza-%20aktualizovany%20DP.rtf>.
  5. Šterclová M. Exogenní alergická alveolitida- navrhovaný doporučený postup pro diagnózu, léčbu a sledování. Dostupný na WWW: <http://www.pneumologie.cz/odborne/doc/Doporuceny%20diagnosticky%20postup%20exogenni%20alergicka%20alveolitid1.doc>.
  6. Lošťáková V, Kolek V, Vašáková M. Sarkoidóza - doporučený postup diagnostiky, terapie a sledování vývoje onemocnění. Dostupný na WWW: <http://www.pneumologie.cz/odborne/doc/Sarkoidoza.doc>.
  7. Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther 2010; 12(4): 213. Go to original source... Go to PubMed...
  8. Chlumský J. Doporučení Sekce patofyziologie dýchání ČPFS pro indikaci a provádění dlouhodobé domácí oxygenoterapie (DDOT). Dostupný na WWW: <http://www.pneumologie.cz/odborne/doc/Standard%20DDOT-%20final.pdf>.
  9. Pafko P, Lischke R, Schűtzner J, Šimonek J, Stolz A. Transplantace plic-indikace. Dostupný na WWW: <http://www.pneumologie.cz/odborne/doc/Transplantace%20plic%20-%20indikace.doc>.
  10. McGrath EE. Hot off the breath: triple therapy for idiopathic pulmonary fibrosis-hear the PANTHER roar. Thorax 2012;67:97-98. Go to original source... Go to PubMed...
  11. Lisá P., Vašáková M. Doporučený postup pro diagnostiku a léčbu plicní histiocytózy z Langerhansových buněk. Dostupný na WWW: <http://www.pneumologie.cz/odborne/doporucene-postupy.php>.
  12. Žurková M, Kolek V, Vašáková M, Loštáková V. Lymfangioleiomyomatóza- standard diagnózy, léčby a sledování. Dostupný na WWW: <http://www.pneumologie.cz/odborne/doc/LAM-_final_MVdef.doc>.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.